These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26863741)

  • 21. Systems biology of antibiotic production by microorganisms.
    Rokem JS; Lantz AE; Nielsen J
    Nat Prod Rep; 2007 Dec; 24(6):1262-87. PubMed ID: 18033579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antibiotics from Nature's chemical inventory.
    Wencewicz TA
    Bioorg Med Chem; 2016 Dec; 24(24):6227-6252. PubMed ID: 27658795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine bacteria and fungi as promising source for new antibiotics.
    Wiese J; Imhoff JF
    Drug Dev Res; 2019 Feb; 80(1):24-27. PubMed ID: 30370576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actinomycetes: still a source of novel antibiotics.
    Genilloud O
    Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
    Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
    J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural products--the future scaffolds for novel antibiotics?
    Butler MS; Buss AD
    Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Joint cultivation of the producers of biologically active substances with other microorganisms (a review)].
    Iakovleva EP
    Prikl Biokhim Mikrobiol; 1983; 19(3):330-46. PubMed ID: 6348730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes].
    Orlova TI; Bulgakova VG; Polin AN
    Antibiot Khimioter; 2015; 60(7-8):47-59. PubMed ID: 26863742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.
    Huang C; Leung RK; Guo M; Tuo L; Guo L; Yew WW; Lou I; Lee SMY; Sun C
    Sci Rep; 2016 Feb; 6():20667. PubMed ID: 26864220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future potential for anti-infectives from bacteria - how to exploit biodiversity and genomic potential.
    Müller R; Wink J
    Int J Med Microbiol; 2014 Jan; 304(1):3-13. PubMed ID: 24119567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging evolutionary paradigms in antibiotic discovery.
    Chevrette MG; Currie CR
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):257-271. PubMed ID: 30269177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high-throughput screen for antibiotic drug discovery.
    Scanlon TC; Dostal SM; Griswold KE
    Biotechnol Bioeng; 2014 Feb; 111(2):232-43. PubMed ID: 23955804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MS network-based screening for new antibiotics discovery.
    Koyama N; Tomoda H
    J Antibiot (Tokyo); 2019 Jan; 72(1):54-56. PubMed ID: 30353113
    [No Abstract]   [Full Text] [Related]  

  • 35. Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening.
    Singh SB; Zhang C; Zink DL; Herath K; Ondeyka J; Masurekar P; Jayasuriya H; Goetz MA; Tormo JR; Vicente F; Martín J; González I; Genilloud O
    J Antibiot (Tokyo); 2013 Oct; 66(10):599-607. PubMed ID: 23801187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial interactions trigger the production of antibiotics.
    Netzker T; Flak M; Krespach MK; Stroe MC; Weber J; Schroeckh V; Brakhage AA
    Curr Opin Microbiol; 2018 Oct; 45():117-123. PubMed ID: 29702423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mining the microbial dark matter.
    Lok C
    Nature; 2015 Jun; 522(7556):270-3. PubMed ID: 26085253
    [No Abstract]   [Full Text] [Related]  

  • 39. Forty years of screening programmes for antibiotics.
    Mochales S
    Microbiologia; 1994 Dec; 10(4):331-42. PubMed ID: 7772289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthetic biology toward microbial secondary metabolites and pharmaceuticals].
    Wu LZ; Hong B
    Yao Xue Xue Bao; 2013 Feb; 48(2):155-60. PubMed ID: 23672010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.